Senior insider sale
Chief Medical Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$221.7K
13.62K shares
What this filing means
KARLIN DANIEL plans to sell 13.62K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $221.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2026ACC: 0001950047-26-003006
Officer· Chief Medical Officer
Since Jan 2022
13.62K
Shares to sell
$221.7K
Approx. market value
8.02K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Services Rendered
3/25/2026
8.02KTotal acquired8.02K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/25/2026 | Restricted stock vesting under a registered plan Services Rendered | 8.02K | — |
| Total | 8.02K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.60K
Market value
$73.6K
12/26/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.02K
Market value
$148.1K
3/25/2026
Total
Units
13.62K
Value
$221.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/26/2025 | 5.60K | $73.6K | — | Completed |
| Planned — Approximate Date | ||||
3/25/2026 | 8.02K | $148.1K | NASDAQ | Planned |
| Total | 13.62K | $221.7K | ||